The Leeds Teaching Hospitals Nhs Trust
Leeds LS9 7TF
1 studies enrolling now · 11 studies all time
What they study most
Atherosclerosis, Chronic Lymphocytic Leukemia, Coronary Artery Disease, Cutaneous Melanoma, Stage II, Leukemia, Myelomonocytic, Chronic, Marginal Zone Lymphoma, Mature B-Cell Malignancies, Myelodysplastic Syndromes, Myocardial Infarction, Neoplasms, Primary Sclerosing Cholangitis, Psoriasis
Studies at this site
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma — Recruiting now
- A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
- Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies — Running, not enrolling
- A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL — Running, not enrolling
- A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma — Completed
- Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs — Completed
- Study of Cilofexor in Adults With Primary Sclerosing Cholangitis — Stopped early
- An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
- An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate — Completed
- Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI) — Completed
- ARISE - Aggressive Reduction of Inflammation Stops Events — Status unconfirmed